GSK Investigational Site is a clinical research site located in North Miami, Florida, United States 33161.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 21 clinical trials.
Therapeutic areas: Social Anxiety Disorder, Anxiety Disorders, Schizophrenia.
Sponsors: GlaxoSmithKline, ViiV Healthcare, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 21 clinical trials on record. Their work covers Social Anxiety Disorder, Anxiety Disorders, Schizophrenia.
Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.